Results 101 to 110 of about 291,345 (345)
Requiring Human Papilloma Virus Vaccination for School Entry [PDF]
, 2018 Over 40,000 Americans are diagnosed as having HPV-associated cancer each year, including oropharyngeal cancer for men and cervical cancer for women.
Bayefsky, Michelle J. +1 more
core +1 more source
Farmeconomia: Health Economics and Therapeutic Pathways, 2012 In Sicilia region 64% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions ...
Roberto Gasparini +9 more
doaj +1 more source
HPV Infections in Adolescents [PDF]
Disease Markers, 2007 Adolescents who are sexually active have the highest rates of prevalent and incident HPV infection rates with over 50–80% having infections within 2–3 years of initiating intercourse. These high rates reflect sexual behavior and biologic vulnerability. Most infections are transient in nature and cause no cytologic abnormality.
openaire +5 more sources
Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer
Head &Neck, EarlyView.ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella +12 more
wiley +1 more source
Australian and New Zealand Journal of Public Health, 2015 Objective: To compare the use of two alternative population‐based denominators in calculating HPV vaccine coverage in Australia by age groups, jurisdiction and remoteness areas. Method: Data from the National HPV Vaccination Program Register (NHVPR) were
Bianca Barbaro, Julia M.L. Brotherton
doaj +1 more source
Level of Student’s Knowledge of Prevention HPV Depending on University Profile
Journal of Education, Health and Sport, 2019 Admission: HPV is the most common sexually transmitted. They can lead to the formation of benign skin lesions, as well as to the development of malignant tumors.
Sylwia Dubiel +2 more
doaj +1 more source
Head &Neck, EarlyView.ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon +6 more
wiley +1 more source
Human Papillomavirus Infection: Prevention, Barriers to Vaccination, and the Need for Education [PDF]
, 2016 While there is no known cure for HPV, prophylactic vaccination provides an effective method of primary prevention against HPV-related diseases. However, many females and males never receive the HPV vaccine as recommended.
Kessler, Theresa A
core +2 more sources
Applying Multiple Data Collection Tools to Quantify Human Papillomavirus Vaccine Communication on Twitter. [PDF]
, 2016 BACKGROUND: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. There are several vaccines that protect against strains of HPV most associated with cervical and other cancers.
Budenz, Alexandra +5 more
core +3 more sources
Prophylactic HPV vaccines [PDF]
Journal of Clinical Pathology, 2007 The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major
openaire +5 more sources